The Prescription Drug Advisory Board is soliciting comments on proposed revisions to COMAR 14.01.04 (cost study process). Written comments are due by 12:00 noon on May 8 to pdab.regs@maryland.gov. For more information, visit the Board’s website.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.